Aura Biosciences, Inc.
Develops Virus-Like Drug Conjugates as targeted therapies for solid tumors.
AURA | US
Overview
Corporate Details
- ISIN(s):
- US05153U1079
- LEI:
- Country:
- United States of America
- Address:
- 80 GUEST STREET, 2135 BOSTON
- Website:
- https://aurabiosciences.com/
- Sector:
- Manufacturing
Description
Aura Biosciences is a clinical-stage biotechnology company developing a new class of targeted therapies for solid tumors. The company's proprietary platform creates Virus-Like Drug Conjugates (VDCs), which use Virus-Like Particles to selectively deliver anti-cancer agents to tumor cells. This approach is designed to destroy cancer while preserving healthy tissue and organ function. Aura's initial focus is on ocular and urologic oncology, with a lead program for the first-line treatment of choroidal melanoma, a rare, vision-threatening eye cancer that lacks approved drug therapies. The company aims to establish a new standard of care across multiple cancer indications.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Aura Biosciences, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Aura Biosciences, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Aura Biosciences, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
